Vensica Medical’s Post

Key takeaways from the PARTEM Trial: PAE provides a significantly greater reduction in International Prostate Symptom Score (IPSS) at 9 months vs combined therapy (-10.0 vs -5.7 point reduction). Learn more about the PARTEM Trial > https://lnkd.in/gScz--e4 #interventionalradiology #IR #embolotherapy #embolization #IRads #MedEd #interventionaloncology #IRadres #PAE #ProstateArteryEmbollization #BPH #menshealth #prostate #prostaticartery #urology

The Partem trial is the first trial comparing Medical therapy to PAE. Join us to discuss the PARTEM trial during our journal club on June 4. Register here: https://lnkd.in/gysKAJHF #interventionalradiology #IR #embolotherapy #embolization #IRads #MedEd #interventionaloncology #IRadres #PAE #ProstateArteryEmbollization #BPH #menshealth #prostate #prostaticartery #urology

Biobot Surgical 𝘄𝗶𝗻𝘀 𝗖𝗘 𝗺𝗮𝗿𝗸 𝗳𝗼𝗿 𝗠𝗼𝗻𝗮 𝗟𝗶𝘀𝗮 𝗥𝗼𝗯𝗼𝘁 🤖 Biobot Surgical has received #CEmark #MonaLisa 2.0 #surgicalrobotic platform for #urology procedure. #MonaLisa is a #robotic #transperineal needle positioning device for #prostate disease management including #BPH, supporting precision in diagnostic and therapeutic interventions. It also features a software component allowing urologists to adjust needle pathway according to deviations in the tissue or needle tip design, to ensure precise targeting. Albert Lee, CEO, said "The CE Certification of Mona Lisa 2.0 is a significant milestone for #BiobotSurgical. With its advanced capabilities, Mona Lisa 2.0 is set to redefine prostate care across Europe. Urologists can now leverage its unmatched precision and adaptability to deliver superior patient outcomes.” #biobot #surgicalrobotics #urology #benignprostatichyperplasia #bph #menshealth #prostatecancer #surgicalrobotics #robotics #roboticsurgery #ai #executivesearch #recruitment

Always energizing to be back at LUGPA- a place where innovation meets real-world practice challenges. If you're interested in seeing how Preveta is using AI to convert data into action, come say hello at Booth #501. Looking forward to connecting with everyone here. #LUGPA2024 #AI #CareNavigation #ClinicalAnalytics

We have shared some exciting announcements throughout the year for The Revi® System, including: 👉 Inclusion in AUA/SUFU Guidelines 👉 New 2-year multi-center data supporting The Revi® System 👉 The publication of a comprehensive meta-analysis in the October issue of the peer-reviewed publication, Advances in Therapy 👉 Announcement of Favorable CMS Decision for 2025 Reimbursement Rates for Revi System’s Implantable Tibial Neuromodulation Therapy Watch the video for key takeaways and visit our new publications and guidelines webpage to learn more: https://lnkd.in/eMGsFCSM #Urology #OAB #ClinicalResearch

With nearly 50% of men over 50 experiencing Benign Prostatic Hyperplasia (BPH), effective management is paramount. This condition not only affects urinary function but also significantly impacts overall quality of life. 🌟 Our Evidence-Based Treatment Approach Offers: • Minimally Invasive Solutions: Reducing hospital stays and improving patient satisfaction. • Precision Medicine: Customized treatments tailored to individual patient profiles based on recent clinical guidelines. • Rapid Recovery Protocols: Patients often resume normal activities within days, significantly enhancing their quality of life. 💬 Discussion Point: What management strategies have you found most effective in your practice for treating BPH? Let’s collaborate to optimize our approaches! #BenignProstaticHyperplasia #Urology #PatientOutcomes #IMDSL #HealthcareInnovation #onemillionhealingsperday #MakeinIndia

Exciting News! 😊 Check out our latest VBP case study from Cheltenham General Hospital! They’ve implemented a system that streamlined the patient pathway for monopolar transurethral resection of the prostate (mTURP) and monopolar transurethral resection of bladder tumour (mTURBT) procedures. The results? Increased day-case rates, reduced readmission rates, and improved patient experience! Read the full case study here, which includes a helpful ‘how-to guide’ on integrating the use of PLASMA+, a NICE-recommended technology for treating enlarged prostates, also recognised in the 2022/23 MedTech Funding Mandate Policy - https://ow.ly/OTLo50TMqVG #HealthcareInnovation #PatientCare #Urology #BPH #MedicalTechnology #HealthcareExcellence #ProstateHealth #MedTech #HospitalManagement #PatientExperience

Diagnosing your symptoms involves a number of significant tests to give you an accurate diagnosis. The doctor may perform anything from laboratory tests to ultrasound imaging and more that narrows it down. For a proper evaluation of your Chronic Cystitis - contact us today. https://lnkd.in/eVTDAitg #ChronicCystitis #CystitisSymptoms #MedicalTreatment #CystitisTherapy #ClinicalSymptoms  #Patients #Urology 

🎥 New Breakthrough in Urethral Stricture Treatment Urologists, are you ready to elevate patient care? Optilume® Drug Coated Balloon offers a minimally invasive, durable solution for recurrent anterior urethral strictures. Backed by clinical data, Optilume delivers sustained results with fewer complications compared to traditional treatments. 🌟 Watch the video below to learn how Optilume is transforming the standard of care for your patients. 👨⚕️💡 #Urology #PatientOutcomes #Urologist #Optilume #MensHealth #StrictureDisease #Movember

The Prolaris® Test. Your partner in ADT decision making. The newest enhancement to the Prolaris report, Absolute Risk Reduction (ARR), is a powerful tool for quantifying the benefits of adding androgen deprivation therapy (ADT) to radiation therapy (RT) in #prostatecancer care. Dr. Richardson emphasizes how Prolaris testing helps healthcare providers effectively communicate the potential benefits of treatment intensification to patients. Learn more by connecting with a Myriad Account Executive in your area today! https://lnkd.in/ghwnEkH6 #urology #biomarkers #radiationoncology #genetictesing